ACCUVAC Trademark

Trademark Overview

On Thursday, January 7, 2021, a trademark application was filed for ACCUVAC with the United States Patent and Trademark Office. The USPTO has given the ACCUVAC trademark a serial number of 90453135. The federal status of this trademark filing is REGISTERED as of Tuesday, October 10, 2023. This trademark is owned by Defence Therapeutics Inc.. The ACCUVAC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines
accuvac

General Information

Serial Number90453135
Word MarkACCUVAC
Filing DateThursday, January 7, 2021
Status700 - REGISTERED
Status DateTuesday, October 10, 2023
Registration Number7185505
Registration DateTuesday, October 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements

Pseudo MarkACCU VAC
Goods and ServicesResearch and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDefence Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6C3L6
CA
Party NameDefence Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver, BC V6C3L6
CA
Party NameDefence Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6C3L6
CA

Trademark Events

Event DateEvent Description
Tuesday, October 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 1, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 31, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 31, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, January 31, 2023SUSPENSION LETTER WRITTEN
Monday, January 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 30, 2023ASSIGNED TO LIE
Friday, January 20, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 26, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, August 26, 2022INQUIRY TO SUSPENSION E-MAILED
Friday, August 26, 2022SUSPENSION INQUIRY WRITTEN
Thursday, August 25, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, February 25, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 25, 2022LETTER OF SUSPENSION E-MAILED
Friday, February 25, 2022SUSPENSION LETTER WRITTEN
Friday, February 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 23, 2022ASSIGNED TO LIE
Wednesday, February 23, 2022ASSIGNED TO LIE
Wednesday, February 16, 2022ASSIGNED TO LIE
Monday, February 14, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 18, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, January 18, 2022INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 18, 2022SUSPENSION INQUIRY WRITTEN
Friday, July 16, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 16, 2021LETTER OF SUSPENSION E-MAILED
Friday, July 16, 2021SUSPENSION LETTER WRITTEN
Thursday, July 15, 2021ASSIGNED TO EXAMINER
Wednesday, April 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 11, 2021NEW APPLICATION ENTERED

Related Keywords

accuvac medicines vaccines development research